Uniject.jpg
FA info icon.svg Angle down icon.svg Medical equipment data
Health topic Maternal mortality
Health classification Treatment
FA info icon.svg Angle down icon.svg Project data
Location New Jersey, United States
Status Commercialized
Instance of Disposable needle
OKH Manifest Download

In the developing world, needles in a medical setting are often reused due to the scarcity of resources. However, reusing old (and possibly contaminated) needles increases the risk of HIV transmission. There was a need for a single-use, safe syringe in order to ensure safe injections.

Detailed description of the solution[edit | edit source]

The Uniject is a single-use needle, designed with a pre-filled drug delivery container that cannot be refilled. This type of needle is effective in preventing "needle sharing" because it can only be used once and provides a sterile injection each time. It is also user-friendly in that medical personnel can be trained to use the Uniject in under two hours (PATH, n.d.). It is compact, convenient, easy to store and increases dosage precision.

Designed by[edit | edit source]

  • Designed by: This device was designed by PATH.
  • Manufacturer (if different): It is licensed and manufactured by Becton, Dickinson and Company (BD).

When and where it was tested/implemented[edit | edit source]

This device was tested in Argentina (Althabe, 2011), Angola (Strand, 2005), Indonesia ("Cost", 2003) and Vietnam ("Oxytocin", 2003).

Funding Source[edit | edit source]

This device has received funding from USAID, BD and UNICEF.

References[edit | edit source]

Peer-reviewed publication[edit | edit source]

Althabe, F., Mazzoni, A., Cafferata, M. L., Gibbons, L., Karolinski, A., Armbruster, D., et al.(2011). Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin America. International Journal of Gynecology and Obstetrics, 114, 184-189.

Strand, R. T., Silva, F. D., Jangsten, E., & Bergstrom, S. (2005). Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration. Acta Obstetricia et Gynecologica Scandinavica, 84, 260-265.

Tsu, V. D., Levin, C., Tran, M. P., Huang, M. V., & Luu, H. T. (2009). Cost-effectiveness analysis of active management of third-stage labour in Vietnam. Health Policy and Planning, 24, 438-444.

Tsu, V., Sutanto, A., Vaidya, K., Coffey, P., & Widjaya, A. (2003). Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia. International Journal of Gynecology and Obstetrics, 83, 103-111.

Other internally generated reports[edit | edit source]

PATH: Uniject. (n.d.). PATH: A catalyst for global health. Retrieved October 21, 2012. Link available here.

UniJect. (n.d.). BD. Retrieved October 21, 2012. PDF available here.

FA info icon.svg Angle down icon.svg Page data
Part of Global Health Medical Device Compendium
SDG SDG03 Good health and well-being
Authors Eva Shiu
License CC-BY-SA-3.0
Language English (en)
Related 0 subpages, 1 pages link here
Impact 324 page views
Created October 30, 2012 by Eva Shiu
Modified January 31, 2023 by Emilio Velis
Cookies help us deliver our services. By using our services, you agree to our use of cookies.